Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 719)
Posted On: 06/08/2024 1:39:41 AM
Post# of 154185
Posted By: My69z
Subclasses of Steatotic Liver Disease Can Help Determine Prognosis

*Disclosures
This study was funded by the EU Horizon 2020 Research and Innovation Program.

Rinella reported scientific consulting for Boehringer Ingelheim, Intercept Pharmaceuticals, Madrigal, NGM Biopharmaceuticals, Novo Nordisk, GlaxoSmithKline, Sonic Incytes, HistoIndex, Takeda, and CytoDyn, and has received support for travel to symposia from GlaxoSmithKline and Novo Nordisk.

https://www.medpagetoday.com/gastroenterology...ogy/108305
_____________
https://www.uchicagomedicine.org/find-a-physi...-e-rinella

1st time seeing her as a consultant, including to both Cytodyn & Madgril.

Consulting with KOL's & our combo Madgril study.

Shall see....

















(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site